chr19-48703417-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000511.6(FUT2):c.461G>A(p.Trp154Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.458 in 1,612,604 control chromosomes in the GnomAD database, including 179,977 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.44 ( 15740 hom., cov: 32)
Exomes 𝑓: 0.46 ( 164237 hom. )
Consequence
FUT2
NM_000511.6 stop_gained
NM_000511.6 stop_gained
Scores
3
3
1
Clinical Significance
Conservation
PhyloP100: 4.26
Genes affected
FUT2 (HGNC:4013): (fucosyltransferase 2 (H blood group)) This gene is one of two encoding the galactoside 2-L-fucosyltransferase enzyme. The encoded protein is important for the final step in the soluble ABO blood group antigen synthesis pathway. It is also involved in cell-cell interaction, cell surface expression, and cell proliferation. Mutations in this gene are a cause of the H-Bombay blood group where red blood cells lack the H antigen. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 19-48703417-G-A is Benign according to our data. Variant chr19-48703417-G-A is described in ClinVar as [Benign]. Clinvar id is 12945.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.493 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FUT2 | NM_000511.6 | c.461G>A | p.Trp154Ter | stop_gained | 2/2 | ENST00000425340.3 | |
LOC105447645 | NR_131188.1 | n.432C>T | non_coding_transcript_exon_variant | 1/1 | |||
FUT2 | NM_001097638.3 | c.461G>A | p.Trp154Ter | stop_gained | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FUT2 | ENST00000425340.3 | c.461G>A | p.Trp154Ter | stop_gained | 2/2 | 1 | NM_000511.6 | P1 | |
FUT2 | ENST00000522966.2 | c.461G>A | p.Trp154Ter | stop_gained | 2/2 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.441 AC: 66996AN: 151762Hom.: 15747 Cov.: 32
GnomAD3 genomes
AF:
AC:
66996
AN:
151762
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.383 AC: 95772AN: 250156Hom.: 21385 AF XY: 0.387 AC XY: 52463AN XY: 135516
GnomAD3 exomes
AF:
AC:
95772
AN:
250156
Hom.:
AF XY:
AC XY:
52463
AN XY:
135516
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.460 AC: 671929AN: 1460728Hom.: 164237 Cov.: 75 AF XY: 0.455 AC XY: 330704AN XY: 726622
GnomAD4 exome
AF:
AC:
671929
AN:
1460728
Hom.:
Cov.:
75
AF XY:
AC XY:
330704
AN XY:
726622
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.441 AC: 67000AN: 151876Hom.: 15740 Cov.: 32 AF XY: 0.429 AC XY: 31842AN XY: 74210
GnomAD4 genome
AF:
AC:
67000
AN:
151876
Hom.:
Cov.:
32
AF XY:
AC XY:
31842
AN XY:
74210
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1830
ALSPAC
AF:
AC:
1924
ESP6500AA
AF:
AC:
2186
ESP6500EA
AF:
AC:
4231
ExAC
AF:
AC:
47143
Asia WGS
AF:
AC:
490
AN:
3414
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
SECRETOR/NONSECRETOR POLYMORPHISM Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Oct 01, 2008 | - - |
Bombay phenotype;C2674252:Vitamin b12 plasma level quantitative trait locus 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 12, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Familial Otitis Media Other:1
confers sensitivity, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | - | - - |
Vitamin b12 plasma level quantitative trait locus 1 Other:1
association, no assertion criteria provided | literature only | OMIM | Oct 01, 2008 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
P;P
Vest4
0.70, 0.53
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at